irinotecan has been researched along with pegamotecan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HL; Cheng, PL; Gao, WJ; Goto, M; Lee, KH; Liu, YQ; Morris-Natschke, SL; Song, ZL; Wang, MJ; Wang, YH; Zhu, GX | 1 |
1 other study(ies) available for irinotecan and pegamotecan
Article | Year |
---|---|
Design and synthesis of novel PEG-conjugated 20(S)-camptothecin sulfonylamidine derivatives with potent in vitro antitumor activity via Cu-catalyzed three-component reaction.
Topics: Antineoplastic Agents; Camptothecin; Catalysis; Cell Line, Tumor; Cell Proliferation; Copper; Drug Design; Drug Screening Assays, Antitumor; Humans; Irinotecan; KB Cells; Polyethylene Glycols; Structure-Activity Relationship | 2015 |